Showing posts with label SHort Pick of the Year. Show all posts
Showing posts with label SHort Pick of the Year. Show all posts

Friday, December 6, 2013

Stockdiagnostics Examines Titan's Q3 Financials

Stockdiagnostics' chief market strategist, Michael Markowski, published the following report Knobias this morning @ 9:56am.



Probability of 2014 Bankruptcy for Titan Increases After it Files Quarterly Report

By Michael Markowski

The probability of Titan Machinery (NASDAQ:TITN:$15.00) having to file for bankruptcy by the end of or sooner than the end of 2014 has increased significantly based on its 3rd quarter 10/31/13 financials that it filed yesterday.  In a report “Tractor Pull for Titan Machinery May be Over by Tomorrow” which was published on December 4, 2013, I had predicted that Titan would file for bankruptcy by the end of 2014.  

Titan’s Income Statement, Balance Sheet and Cash Flow Statement data deteriorated over the 90 day period.  Titan’s revenue for its 3rd quarter increased by less than 1% from $582.1 million in the year ago quarter to $588.0 million.  It also reported that its inventory increased by 10% to $1.2 billion from its quarter ended July 31, 2013.  Finally, Titan operating cash flow for the quarter was a negative $59.8 million.  Titan has generated negative quarterly operating cash flow in nine of its last 10 quarters.

Titan is following a similar script that I have seen played out by numerous companies that StockDiagnostics.com has diagnosed as having “The EPS Syndrome”.  Notable companies who were previously diagnosed with this negative operating cash flow anomaly include Bear Stearns, Merrill Lynch and Lehman Brothers.  Here is the typical script:   

1.                  Company utilizes archaic SEC accrual accounting standards to report growing cashless earnings.
  
2.                  Wall Street analysts recommend shares based on earnings growth.

3.                  Wall Street investment bankers who are affiliated with analysts raise capital for company to generate commissions.

4.                  Commercial banks and suppliers provide loans and credit lines based on the increased equity.

5.                  After the company maximizes its ability to raise additional debt and equity capital revenue growth flattens.

6.                  Company sells inventory at losses and creates declining revenue and EPS losses.

7.                  Company loses option to sell or issue equity to raise capital due to both fundamentals and share price momentum turning negative.  Also loses ability to increase borrowings.

8.                  Company’s fundamentals and share price continue in downward spiral as it liquidates inventory at declining prices to raise cash.

9.                  Company has no choice but to file for bankruptcy since it has debt and can not raise cash.

Titan was first diagnosed as having The EPS Syndrome on September 8, 2011 at a price of $26.41.  Its among several institutionally held public companies who have Wall Street analyst Buy Ratings that StockDiagnostics.com has diagnosed with extreme or severe cases of The EPS Syndrome or cashless earnings. 

There have been 93 companies diagnosed with The EPS Syndrome during 2013 and more than 2,500 since 2002.  The share prices of approximately 70% of the companies diagnosed are below their diagnosis price.  Share prices have fallen by at least 50% for half of those companies that have been diagnosed as having the EPS Syndrome.  A four minute video that explains The EPS Syndrome is available.







Thursday, January 17, 2013

The Most Overpriced Stock in the Market

Including A letter I wrote to a friend today. Stratasys Limited (SSYS) Nasdaq: $87.00 is trading near it's 18 year high of $87 set this past week. Q3 2012 operational cash flow= -($9million) -262% decline Q3 2011 operational cash flow+ $5million 9mos 2012 : $2million in operational, 9mos 2011: $12million in operational cash flow MARKET CAP : $3.4 billion shares outstanding : 41 million average volume this week : 350,000 shares a day company just acquired a private company for $1 billion the first week of December. Stock is Grossly overvalued. Here is a letter I wrote to a friend with links on my research. it may take some time to read it all but if I'm right, there would be a big pay day on the short side trade. My SSYS research has two issues, one is the wild valuation but the second point is the Transparency/Disclosures from the Company and the Online Financial Sites that are using old data but are not disclosing that it is old data. (in other words every mom & pop in the world is home reading old data and have no clue that it's old data). A. SSYS: The trouble I have with SSYS is that the company generated negative operational cash flow for the 3rd Quarter of 2012. Q3 Operational cash flow was Negatice $9.6 million down from positive $5million the prior year Q3. (over 250% decline.) 9mos ending Sept 2012 operational cash flow $2.3 million, $10million decline vs. 9mos ending Sept 2011. (82% DECLINE.) Poor EPS Quality The operational cash flow for the trailing twelve months ending Sept 2012 was a mere $11 million, down 42% from the prior year comparable ttm. For a business generating only generating $11 million operational cash flow to be trading at a $1.8 billion valuation is ridiculous. imo. (that's over 163X operational cash flow). I understand that sometimes small cap super growth companies have such high high multiples, but htis is a company that's been around over 18 years and has only grown these past two years primarily via acquisition, doesn't really excite me. B. On another note: "Be careful When you read any Number on Any Site" Morningstar data regarding SSYS is using November data. The acquisition of Objet was completed the 1st week of December. Since the first week of December the new company Stratasys Limited has 41 million shares outstanding. Therefore the current market capitalization is $3.4 billion. Motley Fool and other Analyst writing about the stock have put out estimates. Not sure where the EPS estimates come from, but are those estimates based on 21 million shares or 41 million shares outstanding? I've been trying to find out. I was on the Needham Conference call the other day and the Company gave NO GUIDANCE. NONE. they made a slight mention about the cash position of the 2 companies combined "as of the 1st Q last year 2012" was $140 million. (so what, right?) I contacted the Wall Street Journal yesterday to get some clarity on why data is unclear, here is there response. The Journal responded by saying that the data won't be updated until the company reports their Year end numbers which are expected in February. Last night I listened to the Needham Conference call and SSYS announced that their year end numbers have been postponed from Feb to approx March 4,2013. Until those figures are updated, the public only has the data available on ZACKS, Yahoo Finance, Bloomberg & Morningstar, CNBC,TheStreet,. The problem is each of those sites are using old data that won't be updated till hopefully March. This leaves many unanswered questions: What is EPS? ball park? What is PE multiple? ballpark? To much uncertainty for anyone to speculate on. What I do know is that the two business valued themselves for the purpose of the merger at ($1 billion for Objet) & ($1.2 billion for SSYS) 45% & 55% Why the shares are hanging around a $3.4 billion market cap 40 days later is questionable imho And here's a nice lawsuit that shareholders in Minnesota brought against company to squash deal only to have SSYS settle with them Have a great day tom 908-477-4796 Disclaimer. All Newsletters, published by Equities Research, LLC , does not constitute a recommendation by Equities Research, LLC to buy, sell, hold any security, or to follow any particular trading or investment strategy. Also, the information provided should not be construed as an offer, or a solicitation of an offer, to buy or sell securities. An investor's best course of action must be based upon individual circumstances. EquitiesResearch.com shall not be liable for any damages or costs of any type arising out of or in any way connected with your use of The Newsletters, or any of our services. EquitiesResearch.com, its officers and employees may buy and sell any position in the securities or companies mentioned herein.